Democratic Gov. Steve Sisolak has signed legislation, Senate Bill 430, expanding the pool of patients eligible for medical cannabis therapy.
Inhaled cannabis is effective and well-tolerated in patients with Tourette’s Syndrome, according to clinical data published online ahead of print in the Journal of Neuropsychiatry and Clinical Neuroscience. They concluded: “Overall, these study participants experienced substantial improvements in their symptoms. This is particularly striking given that almost all participants had failed at least one anti-tic medication trial.
[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To have NORML’s news alerts and legislative advisories delivered straight to your in-box, sign up here.] The use of cannabis and cannabinoids appears to mitigate symptoms associated with post-traumatic stress disorder (PTSD), according to a new review of clinical and preclinical evidence published online in the scientific journal Drug Testing and Analysis. An international team of investigators from Germany, the United States, and the United Kingdom reported that the use of cannabis to “dramatically reduced” PTSD […]
May 25, 2012 Dear NORML supporters in AZ, Good news! The Arizona Department of Health Services (azdhs.gov) who administers the medical cannabis program is apparently soliciting information on peer-reviewed research for the efficacious use of cannabis for four new conditions for consideration of including on the list of conditions acceptable for use under the official program. Those four conditions under consideration are: *Post traumatic stress disorder (PTSD) *Migraines *Depression *Generalized Anxiety Order The administrator, Will Humble, posted to the AZDHS blog on May 24th, 2012 that on “Friday afternoon” (May […]